×
About 388 results

ALLMedicine™ Keratoconjunctivitis Sicca Center

Research & Reviews  123 results

Ocular Manifestations in Rheumatic Diseases
https://clinicaltrials.gov/ct2/show/NCT03753893

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

Microbial Keratitis Associated With Penetrating Keratoplasty and Scleral Lens Wear: A C...
https://doi.org/10.1097/ICL.0000000000000895
Eye & Contact Lens; Kawulok ER, Nau CB et. al.

Mar 26th, 2022 - To report on microbial keratitis (MK) in three scleral lens (SL) wearers who had undergone penetrating keratoplasty (PKP). This retrospective case series describes 3 cases of MK in patients who wore SLs after PKP. All three patients wore SLs for v...

Red Eye
https://emedicine.medscape.com/article/1192122-print

Feb 25th, 2022 - Background A red eye is a cardinal sign of ocular inflammation, which can result from many conditions. Subconjunctival hemorrhage (see the image below), defined as blood between the conjunctiva and the sclera, is usually not secondary to inflammat...

Topical sucralfate for treatment of mucocutaneous conditions: A systematic review on cl...
https://doi.org/10.1111/dth.15334
Dermatologic Therapy; Abtahi-Naeini B, Saffaei A et. al.

Jan 27th, 2022 - Sucralfate is an aluminum salt of sucrose octasulfate, generally considered safe in terms of adverse effects. Systemic sucralfate is FDA-approved for the treatment of duodenal ulcers. Since 1991, topical sucralfate has been used in various mucocut...

An unusual presentation of thymoma: dysgeusia, ulcerative colitis, keratoconjunctivitis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762128
BMJ Case Reports; Sanghi P, Bremner F

Jan 15th, 2022 - A 41-year-old female presented with dysgeusia, dry eyes, nyctalopia with progressive visual field constriction (due to autoimmune retinopathy) and gastrointestinal symptoms (due to ulcerative colitis). She was subsequently admitted to intensive ca...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  8 results

Ocular Manifestations in Rheumatic Diseases
https://clinicaltrials.gov/ct2/show/NCT03753893

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
https://clinicaltrials.gov/ct2/show/NCT04440280

Oct 7th, 2021 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...

Effect of Ciclosporin Eyedrops on Sjögren Syndrome
https://clinicaltrials.gov/ct2/show/NCT04597762

Apr 8th, 2021 - Keratoconjunctivitis sicca, also known as dry eye syndrome, is one of the most common ophthalmological diseases and is treated with tear substitutes to moisten the surface of the eye and, in more severe cases of this disease, with local anti-infla...

Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
https://clinicaltrials.gov/ct2/show/NCT00128245

May 27th, 2020 - This study evaluates the efficacy and safety of 2 doses of pimecrolimus (0.3% and 1%) ophthalmic suspension in a moderate to severe population of keratoconjunctivitis sicca (KCS, dry eye syndrome) patients.

Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)
https://clinicaltrials.gov/ct2/show/NCT03418259

Feb 11th, 2020 - The purpose of the study is to evaluate how treatment with Intra-Nasal Mechanical Stimulation (INMEST) in the nasal cavity in patients with Keratoconjunctivitis sicca can relieve these symtoms.

see more →

News  11 results

FDA Approves First Generic Version of Restasis for Dry Eye
https://www.medscape.com/viewarticle/967849

Feb 3rd, 2022 - The US Food and Drug Administration (FDA) has approved the first generic of cyclosporine ophthalmic emulsion (Restasis) to treat keratoconjunctivitis sicca (dry eye). Restasis has been approved by the FDA since 2003 and works to help increase tear...

Fast Five Quiz: Psoriatic Arthritis Presentation and Diagnosis
https://reference.medscape.com/viewarticle/922805_4

Jan 29th, 2020 - Recognizing the patterns of joint involvement seen in psoriatic arthritis is essential to its diagnosis. Five patterns have been identified. They are: Asymmetrical oligoarticular arthritis Symmetrical polyarthritis Arthritis mutilans Distal interp...

FDA Clears New Treatment for Dry Eye (Cequa)
https://www.medscape.com/viewarticle/900888

Aug 17th, 2018 - The US Food and Drug Administration (FDA) has approved cyclosporine A ophthalmic solution 0.09% (Cequa, Sun Pharmaceuticals) to increase tear production in patients with keratoconjunctivitis sicca (dry eye), the company has announced. Cequa is a p...

Fast Five Quiz: Are You Familiar With Dry Eye Disease?
https://reference.medscape.com/viewarticle/886154

Sep 29th, 2017 - Dry eye disease, also known as keratoconjunctivitis sicca and keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability. Dry eye disease is a common f...

Fast Five Quiz: Are You Familiar With Dry Eye Disease?
https://reference.staging.medscape.com/viewarticle/886154

Sep 29th, 2017 - Dry eye disease, also known as keratoconjunctivitis sicca and keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability. Dry eye disease is a common f...

see more →

Patient Education  1 results see all →